Skip to Main Content

Paper Details

Costs of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological response.
Hepatology
34
2014
HCV, IFN, Peg-IFN, RBV, SVR, TVR, cirrhosis, hepatitis C, hepatitis C virus, hepatitis C virus [HCV] RNA, human, human immunodeficiency virus/HCV coinfection, patient, patients, pegylated interferon, ribavirin, telaprevir

Datasets

Release 1.2